
Engineering a lysin by fusion of antimicrobial peptides enhances its antibacterial properties
Endolysins are the future against antibiotic-resistant bacteria. These enzymes, produced by bacteriophage viruses, kill bacteria by degrading the peptidoglycan layer that forms the cell wall.